Roche boosts 2019 sales outlook, sees Spark deal this year Reuters Oct 17, 2019 Sales in the third quarter rose 13 per cent to 15.6 billion Swiss francs ($15.64 billion), the Basel-based drugmaker said, citing…
Mylan and Biocon launch first Trastuzumab Biosimilar, Ogivri, in Australia EP News Bureau Aug 1, 2019 Ogivri is the first trastuzumab biosimilar approved and launched in Australia and available on the Pharmaceutical Benefits Scheme…
